June 25, 2020 – Vancouver, BC: The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (FE:YG3) (“Yield Growth”) is pleased to announce it has received 23 new cosmetic notification (“CN”) numbers from Health Canada for its proprietary plant-based products to be launched under various brand collections.
Yield Growth submitted products across a variety of cosmetic categories for notification to Health Canada in March. On June 24, 2020, Yield Growth received confirmation that Health Canada acknowledged and approved its submissions and provided CN numbers for the following 23 plant-based products:
- Eye Cream
- Face & Eye Cleanser
- Face & Body Mist
- Nail Cuticle Oil
- Deodorants (2 products)
- Shaving Cream
- Beard Oils (2 products)
- Scented Roll-Ons (8 products)
- Perfume Roll-Ons (6 products)
Yield Growth was founded on the belief that there had to be a better way – a philosophy of creating natural, plant-based products that work to improve health and wellness. Today, its brands, its products, and its people are all driven by the desire to play a role in enhancing people’s lives. Yield Growth selects plant-based, high-efficacy ingredients to offer products at accessible price points.
“We believe there is increasing value being placed by consumers on high-quality, plant-based, small-batch products that are responsibly made,” says Yield Growth CEO Penny White. “Leveraging the expertise we have gained developing our extensive catalogue of proprietary plant-based product formulations, we believe we are well positioned to capitalize on this opportunity in the marketplace.”
“Your skin is an indicator of what’s going on inside your body,” says Bhavna Solecki, Head of Product Development at Yield Growth. “Our mission is to restore the physical and emotional wellbeing of individuals with our pure, all-natural, and environmentally friendly wellness solutions.”
Consumers today are increasingly concerned about the potential negative side effects for individuals and the environment of chemicals and animal-based ingredients in cosmetics and other products. According to a 2018 report by Grand View Research, Inc., “the global vegan cosmetics market size is projected to reach USD $20.8 billion by 2025, progressing at a CAGR of 6.3% during the forecast period…consumers embracing natural substitutes such as plant-based personal care products is working in favor of the market.”
About The Yield Growth Corp.
The Yield Growth Corp. (CSE: BOSS),(OTCQB: BOSQF) is a phytoceutical and consumer packaged goods company that develops and acquires intellectual property and other assets related to plant-based products and therapeutics, and develops, manufactures, markets, sells and distributes plant-based products that improve lives. It has over 200 proprietary wellness formulas at various stages of commercialization, including over 20 products that are now for sale through e-commerce or brick and mortar retail stores. It is currently launching several hand sanitizer products in response to COVID-19. It has 14 patent applications filed in what the Global Wellness Institute reports is a $4.2 trillion-dollar global wellness market. Its majority owned subsidiary NeonMind Biosciences Inc. is launching a line of medicinal mushroom products and is developing intellectual property in the emerging area of psychedelic medicine. The Yield Growth management team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, Skechers and Aritzia.
Investor Relations Contacts:
Penny White, President & CEO
Kevan Matheson, Investor Relations
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.
Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies do to the spread of the Coronavirus, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company’s products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.